Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
54 hedge funds and large institutions have $58M invested in Psychemedics Corporation in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
6% more funds holding
Funds holding: 51 → 54 (+3)
1% less capital invested
Capital invested by funds: $58.4M → $58M (-$417K)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
Top Sellers
PMD Hedge Fund Activity: Q3 2018 in Review
54 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2018, worth a combined $58M — down 0.71% from $58.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PMD positions and 1 closed out — a net gain of 4 holders — while 18 added to existing stakes and 19 trimmed.
The largest buyer was DePrince Race & Zollo Inc (DRZ), adding an estimated $4.56M. The largest seller was Moors & Cabot, cutting an estimated $6.38M.
- 54 institutional investors held Psychemedics Corporation (PMD) as of Q3 2018, up from 51 in Q2 2018.
- Funds reported $58M of Psychemedics Corporation stock for Q3 2018, down 0.71% quarter-over-quarter.
- 5 funds opened new Psychemedics Corporation positions in Q3 2018 and 1 closed out, a net change of +4 holders.
- The largest Psychemedics Corporation buyer in Q3 2018 was DePrince Race & Zollo Inc (DRZ), an estimated $4.56M added.
- The largest Psychemedics Corporation seller in Q3 2018 was Moors & Cabot, an estimated $6.38M sold.
Based on aggregated 13F filings for Q3 2018.